2021 - 2026 Strategic Plan

Cystic Fibrosis Australia is the peak patient body in Australia and supports the broad cystic fibrosis community through advocacy, research, and clinical improvement. A new era of medications is upon us, medications capable of targeting the basic defect in the cells of people with CF. These medications will have an unprecedented positive impact on the lives of people with CF.

> Increased access to a wide-range of high-quality treatments to reduce the burden of the disease.

> Delivery of world-class clinical care with Australian standards setting international benchmarks.

> Enhancing the capability and capacity of research and innovation in Australia into CF. 

It is time to plan for the future.